Calithera Biosciences, Inc.
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company…
Biotechnology
US, South San Francisco [HQ]
Balance Sheet
11 Sheets · Starting from 2012In Million USD. Margins, Growth Rates In %
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 3.00 | 34.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Current
|
2.00 | 34.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Cash And Equivalents | 2.00 | 33.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Assets | 3.00 | 34.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Short Term Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Assets | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Non Current
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Property, Plant, Equipment (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Liabilities | 11.00 | 55.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Current
|
- - | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Short Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Deferred Revenue | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | - - | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Non Current
|
10.00 | 54.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | 10.00 | 54.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Equity | -8.00 | -20.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Stockholders' Equity | -8.00 | -20.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Retained Earnings | -17.00 | -30.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -7.00 | -12.00 | -21.00 | -32.00 | -38.00 | -27.00 | -51.00 | -86.00 | -88.00 | -165.00 | -18.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 20.00 | 10.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |